Herpes Simplex D006561

Diseases [C] » Infections [C01] » Virus Diseases » DNA Virus Infections » Herpesviridae Infections » Herpes Simplex

Diseases [C] » Infections [C01] » Virus Diseases » Skin Diseases, Viral » Herpes Simplex

Description

A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.)   MeSH

Subtype Terms (5)

Herpes Genitalis
23 drugs (6 approved, 17 experimental)

Herpes Labialis
37 drugs (16 approved, 21 experimental)

Kaposi Varicelliform Eruption
 

Keratitis, Herpetic
8 drugs (6 approved, 2 experimental)

Stomatitis, Herpetic
4 drugs (3 approved, 1 experimental)


Approved Indicated Drugs (1)

Phase 4 Indicated Drugs (1)


Organization Involved with Other Experimental Indications (2)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.